O'Shaughnessy Asset Management, LLC Genfit S.A. Transaction History

O'Shaughnessy Asset Management, LLC

  • $10.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$3.15 - $4.12 $59,289 - $77,546
-18,822 Reduced 58.05%
13,601 $44,000
Q2 2023

Aug 11, 2023
BUY
$3.54 - $4.68 $28,181 - $37,257
7,961 Added 32.54%
32,423 $114,000
Q1 2023

May 12, 2023
BUY
$3.93 - $4.69 $21,929 - $26,170
5,580 Added 29.55%
24,462 $100,000
Q4 2022

Feb 10, 2023
SELL
$3.53 - $4.39 $113,362 - $140,980
-32,114 Reduced 62.97%
18,882 $82,000
Q3 2022

Nov 14, 2022
BUY
$3.26 - $4.86 $166,246 - $247,840
50,996 New
50,996 $186,000

Others Institutions Holding GNFT

# of Institutions
5
Shares Held
77.7K
Call Options Held
0
Put Options Held
0
View Full List

About Genfit S.A.

GNFT Quotes by TradingView
  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $224M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email